Related references
Note: Only part of the references are listed.HDM2 Regulation by AURKA Promotes Cell Survival in Gastric Cancer
Vikas Sehdev et al.
CLINICAL CANCER RESEARCH (2014)
Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas
Jonathan W. Friedberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion
T-V Do et al.
ONCOGENE (2014)
The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas
Vikas Sehdev et al.
CANCER (2013)
STAT3 is involved in esophageal carcinogenesis through regulation of Oct-1
Zhipeng Wang et al.
CARCINOGENESIS (2013)
Silencing of the transcription factor STAT3 sensitizes lung cancer cells to DNA damaging drugs, but not to TNFα- and NK cytotoxicity
Dorota W. Kulesza et al.
EXPERIMENTAL CELL RESEARCH (2013)
Aurora Kinase A Promotes Inflammation and Tumorigenesis in Mice and Human Gastric Neoplasia
Ahmed Katsha et al.
GASTROENTEROLOGY (2013)
Aurora Kinase-A Inactivates DNA Damage-Induced Apoptosis and Spindle Assembly Checkpoint Response Functions of p73
Hiroshi Katayama et al.
CANCER CELL (2012)
Targeting STAT3 in gastric cancer
Andrew S. Giraud et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Reciprocal Activation Between PLK1 and Stat3 Contributes to Survival and Proliferation of Esophageal Cancer Cells
Yu Zhang et al.
GASTROENTEROLOGY (2012)
Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
Ursula A. Matulonis et al.
GYNECOLOGIC ONCOLOGY (2012)
The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells
Vikas Sehdev et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells
L. Y. W. Bourguignon et al.
ONCOGENE (2012)
Helicobacter pylori CagA Triggers Expression of the Bactericidal Lectin REG3γ via Gastric STAT3 Activation
Kai Syin Lee et al.
PLOS ONE (2012)
A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation
Zhonghan Li et al.
NATURE COMMUNICATIONS (2012)
Aurora kinase A critically contributes to the resistance to anti-cancer drug cisplatin in JAK2 V617F mutant-induced transformed cells
Kazuya Sumi et al.
FEBS LETTERS (2011)
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival
A. Scuto et al.
LEUKEMIA (2011)
Aurora-A Is Essential for the Tumorigenic Capacity and Chemoresistance of Colorectal Cancer Stem Cells
Patrizia Cammareri et al.
CANCER RESEARCH (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Stat3: linking inflammation to epithelial cancer - more than a gut feeling?
Andrew Jarnicki et al.
CELL DIVISION (2010)
Shared and separate functions of polo-like kinases and aurora kinases in cancer
Susanne M. A. Lens et al.
NATURE REVIEWS CANCER (2010)
Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer How Intimate Is the Relationship?
Bharat B. Aggarwal et al.
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)
Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
Tobias Otto et al.
CANCER CELL (2009)
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
Michael Hedvat et al.
CANCER CELL (2009)
Helicobacter pylori Cytotoxin-Associated Gene A Activates the Signal Transducer and Activator of Transcription 3 Pathway In vitro and In vivo
Dana M. Bronte-Tinkew et al.
CANCER RESEARCH (2009)
The aurora kinase A regulates GSK-3β in gastric cancer cells
A. A. Dar et al.
ONCOGENE (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
STAT3 can be activated through paracrine signaling in breast epithelial cells
Jacqueline C. Lieblein et al.
BMC CANCER (2008)
Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinornas correlates with potent antiapoptotic functions
Altaf A. Dar et al.
CANCER (2008)
Aurora Kinase A Inhibition Leads to p73-Dependent Apoptosis in p53-Deficient Cancer Cells
Altaf A. Dar et al.
CANCER RESEARCH (2008)
Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression
C. B. Jackson et al.
JOURNAL OF PATHOLOGY (2007)
Stat3 as a potential target for cancer immunotherapy
Marcin Kortylewski et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells (Publication with Expression of Concern. See vol. 144, 2019)
Hua Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
STAT3-mediated transcription of Bcl-2, Mcl-1 and c-lAP2 prevents apoptosis in polyamine-depleted cells
S Bhattacharya et al.
BIOCHEMICAL JOURNAL (2005)
Epidemiology of gastric cancer in Japan
M Inoue et al.
POSTGRADUATE MEDICAL JOURNAL (2005)
Amplification and overexpression of Aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells
CM Chung et al.
MOLECULAR CARCINOGENESIS (2005)
Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival
HT Liu et al.
BLOOD (2003)
Share Paper
